Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR

被引:43
作者
Andersen, MR [1 ]
Farin, FM [1 ]
Omiecinski, CJ [1 ]
机构
[1] Univ Washington, Dept Environm Hlth, Seattle, WA 98105 USA
关键词
D O I
10.1089/dna.1998.17.231
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We developed a quantitative competitive reverse transcriptase-polymerase chain reaction (QC RT-PCR) assay to measure mRNA levels of seven human cytochrome P450 (P450, CYP) genes and microsomal epoxide hydrolase (EH) simultaneously, This assay employs an exogenous recombinant RNA (rcRNA) molecule as an internal standard that shares PCR primer and hybridization probe sequences with CYP1A1, CYP1A2, CYP2A6/7, CYP2D6, CYP2E1, CYP2F1, CYP3A4/5/7, and EH mRNA, Because each rcRNA molecule contains several primer sequences, an entire battery of genes that exhibit differential responsiveness to various classes of xenobiotics may be measured simultaneously from one population of cDNA molecules, In this study, we demonstrated the precision and power of the assay using small amounts of human liver total RNA, We also report for the first time quantitative profiles of P450 and EH mRNA abundance in eight human livers, Cytochrome P450 2E1 mRNA maintained the highest abundance (average 6.67 x 10(7) molecules/mu g of total RNA) and least variation (13 fold) in all livers examined, Cytochrome P450 1A2, CYP2A6/7, CYP2D6, CYP3A4/5, and EH mRNAs were approximately one order of magnitude less abundant than CYP2E1 transcripts, with CYP2D6 levels exhibiting the greatest variation (220 fold) between individuals, This QC RT-PCR assay should prove valuable for measuring basal and induced mRNAs in different cell types in vitro, as well as in biomonitoring applications where individuals are exposed or hypersusceptible to certain xenobiotic-initiated toxicities.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 27 条
[1]   Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR [J].
Agarwal, VR ;
Bulun, SE ;
Simpson, ER .
MOLECULAR AND CELLULAR PROBES, 1995, 9 (06) :453-464
[2]  
ALI SA, 1995, BIOTECHNIQUES, V18, P746
[3]  
Carcillo JA, 1996, RES COMMUN MOL PATH, V91, P149
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Nomenclature for human CYP2D6 alleles [J].
Daly, AK ;
Brockmoller, J ;
Broly, F ;
Eichelbaum, M ;
Evans, WE ;
Gonzalez, FJ ;
Huang, JD ;
Idle, JR ;
IngelmanSundberg, M ;
Ishizaki, T ;
JacqzAigrain, E ;
Meyer, UA ;
Nebert, DW ;
Steen, VM ;
Wolf, CR ;
Zanger, UM .
PHARMACOGENETICS, 1996, 6 (03) :193-201
[6]   REGIOSPECIFIC EXPRESSION OF CYTOCHROME-P-450S AND MICROSOMAL EPOXIDE HYDROLASE IN HUMAN BRAIN-TISSUE [J].
FARIN, FM ;
OMIECINSKI, CJ .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1993, 40 (2-3) :317-335
[7]   CANCER MORTALITY IN WORKERS EXPOSED TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
FINGERHUT, MA ;
HALPERIN, WE ;
MARLOW, DA ;
PIACITELLI, LA ;
HONCHAR, PA ;
SWEENEY, MH ;
GREIFE, AL ;
DILL, PA ;
STEENLAND, K ;
SURUDA, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (04) :212-218
[8]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[9]   MOLECULAR-GENETICS OF THE P-450 SUPERFAMILY [J].
GONZALEZ, FJ .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :1-38
[10]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407